Coloplast A/S - Annual Report 2025/26 & Remuneration Report 2025/26
FY 2025/26 organic growth was 6% and EBIT growth1 in constant currencies was 4%. Reported revenue in DKK grew 4%, reflecting 2%-points negative impact from currencies.
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.comSummary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.